🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Use of Lubricant Gel to Shorten the Second Stage of Labor During Vaginal Delivery

RecruitingNAAges 18 Years - 49 YearsFemaleUniversidad Nacional Autonoma de Honduras
NCT07428317 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This experimental study aims to evaluate whether the application of obstetric lubricant gel during vaginal delivery can significantly reduce the duration of the second stage of labor, preserve perineal integrity, and decrease the need for episiotomies. The study hypothesis is that lubricant gel facilitates fetal passage through the birth canal by reducing friction, shortening the expulsion phase and reducing maternal-neonatal complications. Two groups will be included: with and without gel application. Follow-up will span from admission of the pregnant woman until immediate postpartum discharge.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Signed informed consent form * Willingness to comply with study procedures * Age between 18 and 40 years * Term pregnancy (37-41.6 weeks) with active labor * Diagnosis of spontaneous labor and planned vaginal delivery * Fetus in cephalic presentation * Agreement to comply with lifestyle restrictions during the study Exclusion Criteria: * Multiple pregnancy * Previous cesarean section * High-risk pregnancy (preeclampsia, uncontrolled gestational diabetes, etc.) * Presence of fever or active infection * Contraindication for vaginal delivery * Refusal to sign informed consent * Premature rupture of membranes \>18 hours without labor * Known allergy to lubricant gel components * Participation in another clinical trial in the last 3 months
💊

What it tests

  • Obstetric Lubricant Gel
  • Standard Active Management of Second Stage
📍

Where

1 site
Hospital Escuela
Tegucigalpa, Honduras
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy